Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer's disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

Two new assessments of clinical trials pointed to the need for more investment in Alzheimer's disease treatments. At the 2024 American Geriatrics Society (AGS) scientific meeting, researchers ...

The scrutiny follows allegations of data manipulation and misleading claims about the drug's effectiveness, leading the Securities and Exchange Commission to charge the company, which resulted in a ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

New research from the University of Surrey has revealed that the time of day when blood is taken can significantly impact ...